Literature DB >> 22843227

Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson's disease and normal control.

Hee Young Shin1, Eun Youn Joo, Seong Tae Kim, Hun-Jong Dhong, Jin Whan Cho.   

Abstract

Rapid eye movement (REM) sleep behavior disorder (RBD) is a preclinical feature of synucleinopathies, such as Parkinson's disease (PD).This study aimed to investigate the presence of potential early manifestations of parkinsonism, such as olfactory dysfunction and substantia nigra (SN) hyperechogenicity, in idiopathic RBD (iRBD) patients, PD patients and normal controls. We performed an olfactory function test using the cross-cultural smell identification test (CC-SIT) and midbrain transcranial sonography (TCS) in 15 patients with iRBD as confirmed by polysomnography, 30 patients with PD, and 30 normal controls. The CC-SIT scores of the iRBD patients and PD patients were significantly lower than those of the normal controls and similar between iRBD and PD (mean ± SD, 7.1 ± 2.2 and 7.6 ± 2.4 vs. 10.4 ± 1.2, respectively, p < 0.01). The sum of bilateral SN echosignals in the iRBD patients was greater than that of the normal controls but lower than that of the PD patients (0.29 ± 0.47, 0.11 ± 0.17 and 0.72 ± 0.41 cm(2), respectively, p < 0.01). In conclusion, we found that the concomitant abnormality of olfaction and increased SN echogenicity was more frequent in iRBD compared with normal control. Olfactory dysfunction and SN hyperechogenicity could be preclinical manifestations of parkinsonism in iRBD patients.

Entities:  

Mesh:

Year:  2012        PMID: 22843227     DOI: 10.1007/s10072-012-1164-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  28 in total

1.  Decreased striatal dopaminergic innervation in REM sleep behavior disorder.

Authors:  R L Albin; R A Koeppe; R D Chervin; F B Consens; K Wernette; K A Frey; M S Aldrich
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

2.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

3.  REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.

Authors:  D O Claassen; K A Josephs; J E Ahlskog; M H Silber; M Tippmann-Peikert; B F Boeve
Journal:  Neurology       Date:  2010-07-28       Impact factor: 9.910

4.  Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT.

Authors:  Marcus M Unger; Jens C Möller; Karin Stiasny-Kolster; Katharina Mankel; Daniela Berg; Uwe Walter; Helmut Hoeffken; Geert Mayer; Wolfgang H Oertel
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

5.  123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.

Authors:  Tomoyuki Miyamoto; Masayuki Miyamoto; Keisuke Suzuki; Momoka Nishibayashi; Masaoki Iwanami; Koichi Hirata
Journal:  Sleep       Date:  2008-05       Impact factor: 5.849

6.  Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease.

Authors:  Ji Youn Kim; Won Yong Lee; Eun Joo Chung; Hun-Jong Dhong
Journal:  Mov Disord       Date:  2007-08-15       Impact factor: 10.338

Review 7.  The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases.

Authors:  Alex Iranzo; Joan Santamaria; Eduard Tolosa
Journal:  Sleep Med Rev       Date:  2009-04-10       Impact factor: 11.609

8.  Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Authors:  R L Doty; D A Deems; S Stellar
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

9.  Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT).

Authors:  R L Doty; A Marcus; W W Lee
Journal:  Laryngoscope       Date:  1996-03       Impact factor: 3.325

10.  Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

Authors:  K Stiasny-Kolster; Y Doerr; J C Möller; H Höffken; T M Behr; W H Oertel; G Mayer
Journal:  Brain       Date:  2004-11-17       Impact factor: 13.501

View more
  8 in total

Review 1.  Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.

Authors:  Birgit Högl; Ambra Stefani; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2017-11-24       Impact factor: 42.937

2.  Risk factors for probable REM sleep behavior disorder: A community-based study.

Authors:  Janice C Wong; Junjuan Li; Milena Pavlova; Shuohua Chen; Aiping Wu; Shouling Wu; Xiang Gao
Journal:  Neurology       Date:  2016-01-27       Impact factor: 9.910

3.  Abnormal Olfaction in Parkinson's Disease Is Related to Faster Disease Progression.

Authors:  Sara Cavaco; Alexandra Gonçalves; Alexandre Mendes; Nuno Vila-Chã; Inês Moreira; Joana Fernandes; Joana Damásio; Armando Teixeira-Pinto; António Bastos Lima
Journal:  Behav Neurol       Date:  2015-06-02       Impact factor: 3.342

Review 4.  Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson's disease: A Systematic Review and Meta-analysis.

Authors:  Dun-Hui Li; Ya-Chao He; Jun Liu; Sheng-Di Chen
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

5.  Odor Identification Test in Idiopathic REM-Behavior Disorder and Parkinson's Disease in China.

Authors:  Si-Fei Huang; Kui Chen; Jian-Jun Wu; Feng-Tao Liu; Jue Zhao; Wei Lin; Si-Si Guo; Yi-Xuan Wang; Ying Wang; Su-Shan Luo; Yi-Min Sun; Zheng-Tong Ding; Huan Yu; Jian Wang
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

Review 6.  Neuroimaging in pre-motor Parkinson's disease.

Authors:  Thomas R Barber; Johannes C Klein; Clare E Mackay; Michele T M Hu
Journal:  Neuroimage Clin       Date:  2017-04-21       Impact factor: 4.881

Review 7.  Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson's Disease and Other Synucleinopathies.

Authors:  Matej Skorvanek; Eva Feketeova; Monica M Kurtis; Jan Rusz; Karel Sonka
Journal:  Front Neurol       Date:  2018-05-25       Impact factor: 4.003

8.  Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease.

Authors:  Dareia S Roos; Jos W R Twisk; Pieter G H M Raijmakers; Richard L Doty; Henk W Berendse
Journal:  J Neural Transm (Vienna)       Date:  2019-09-12       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.